Head and Neck Cancer Trial, Recruiting NCT06307314 Sponsor: Nanfang Hospital, Southern Medical University Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT06307314
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years of age
  • People who are willing to voluntarily sign a consent form to take part
  • People who have been diagnosed with nasopharyngeal carcinoma (a type of cancer at the back of the nose) or a head and neck tumour
  • People whose treatment plan includes radiotherapy
  • People with a general health and activity level score of 0 or 1 on a standard medical scale, meaning they are either fully active or have only minor restrictions on physical activity (confirm with trial site)

Who may not be able to join:

  • People for whom radiotherapy is medically unsafe or not recommended
  • People who have been diagnosed with more than one type of cancer at the same time
  • People who have serious ongoing health conditions that could make participation risky or difficult, such as unstable heart disease requiring treatment, chronic hepatitis, kidney disease, poorly controlled diabetes, or mental illness
  • People who, in the opinion of the trial doctor, are considered unsuitable for the study for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jian Guan, Ph.D., Nanfang Hospital, Southern Medical University

Phone: +8613632102247

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nanfang Hospital, Southern Medical University
Registry
ClinicalTrials.gov
Start date
1 February 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Different grades radiotherapy-induced oral mucositis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov